Collegium Pharmaceutical (COLL) Payables (2016 - 2025)
Collegium Pharmaceutical (COLL) has 10 years of Payables data on record, last reported at $7.6 million in Q3 2025.
- For Q3 2025, Payables rose 143.38% year-over-year to $7.6 million; the TTM value through Sep 2025 reached $7.6 million, up 143.38%, while the annual FY2024 figure was $3.9 million, 54.74% down from the prior year.
- Payables reached $7.6 million in Q3 2025 per COLL's latest filing, down from $10.9 million in the prior quarter.
- Across five years, Payables topped out at $17.9 million in Q1 2025 and bottomed at $2.4 million in Q2 2024.
- Average Payables over 5 years is $6.3 million, with a median of $6.0 million recorded in 2024.
- Peak YoY movement for Payables: crashed 63.48% in 2023, then surged 351.49% in 2025.
- A 5-year view of Payables shows it stood at $4.2 million in 2021, then dropped by 16.59% to $3.5 million in 2022, then surged by 148.77% to $8.7 million in 2023, then tumbled by 54.74% to $3.9 million in 2024, then surged by 94.38% to $7.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Payables were $7.6 million in Q3 2025, $10.9 million in Q2 2025, and $17.9 million in Q1 2025.